世界の4価インフルエンザワクチン市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Quadrivalent Flu Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-105X13967
• 出版社/出版日： / 2021年5月
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料では、4価インフルエンザワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。4価インフルエンザワクチンの種類別市場規模（筋肉注射、点鼻薬、皮内注射）、用途別市場規模（病院、診療所、保健所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・4価インフルエンザワクチンの市場概要
・企業情報（企業概要、製品概要、販売量、価格、売上）：Sanofi Pasteur、AstraZeneca、CSL、Abbott、GlaxoSmithKline
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：筋肉注射、点鼻薬、皮内注射
・用途別分析2016年-2026年：病院、診療所、保健所、その他
・4価インフルエンザワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・4価インフルエンザワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・4価インフルエンザワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・4価インフルエンザワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン
・4価インフルエンザワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Quadrivalent Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Quadrivalent Flu Vaccine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Quadrivalent Flu Vaccine market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Quadrivalent Flu Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Intramuscular Injection
Nasal Spray
Intradermal Shot

Market segment by Application can be divided into
Hospital
Clinic
Public Health Agency
Other

The key market players for global Quadrivalent Flu Vaccine market are listed below:
Sanofi Pasteur
AstraZeneca
CSL
Abbott
GlaxoSmithKline

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Quadrivalent Flu Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Quadrivalent Flu Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Intramuscular Injection
1.2.3 Nasal Spray
1.2.4 Intradermal Shot
1.3 Market Analysis by Application
1.3.1 Overview: Global Quadrivalent Flu Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Public Health Agency
1.3.5 Other
1.4 Global Quadrivalent Flu Vaccine Market Size & Forecast
1.4.1 Global Quadrivalent Flu Vaccine Sales in Value (2016-2026))
1.4.2 Global Quadrivalent Flu Vaccine Sales in Volume (2016-2026)
1.4.3 Global Quadrivalent Flu Vaccine Price by Type (2016-2026) & (USD/Dose)
1.5 Global Quadrivalent Flu Vaccine Production Capacity Analysis
1.5.1 Global Quadrivalent Flu Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Quadrivalent Flu Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Quadrivalent Flu Vaccine Market Drivers
1.6.2 Quadrivalent Flu Vaccine Market Restraints
1.6.3 Quadrivalent Flu Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur Quadrivalent Flu Vaccine Product and Services
2.1.4 Sanofi Pasteur Quadrivalent Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Quadrivalent Flu Vaccine Product and Services
2.2.4 AstraZeneca Quadrivalent Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Quadrivalent Flu Vaccine Product and Services
2.3.4 CSL Quadrivalent Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Quadrivalent Flu Vaccine Product and Services
2.4.4 Abbott Quadrivalent Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Quadrivalent Flu Vaccine Product and Services
2.5.4 GlaxoSmithKline Quadrivalent Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Quadrivalent Flu Vaccine Sales by Manufacturer
3.1 Global Quadrivalent Flu Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Quadrivalent Flu Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Quadrivalent Flu Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Quadrivalent Flu Vaccine Manufacturer Market Share
3.4.2 Top 6 Quadrivalent Flu Vaccine Manufacturer Market Share
3.5 Global Quadrivalent Flu Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Quadrivalent Flu Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Quadrivalent Flu Vaccine Market Size by Region
4.1.1 Global Quadrivalent Flu Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Quadrivalent Flu Vaccine Revenue by Region (2016-2026)
4.2 North America Quadrivalent Flu Vaccine Revenue (2016-2026)
4.3 Europe Quadrivalent Flu Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Quadrivalent Flu Vaccine Revenue (2016-2026)
4.5 South America Quadrivalent Flu Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Quadrivalent Flu Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Quadrivalent Flu Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Quadrivalent Flu Vaccine Revenue by Type (2016-2026)
5.3 Global Quadrivalent Flu Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Quadrivalent Flu Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Quadrivalent Flu Vaccine Revenue by Application (2016-2026)
6.3 Global Quadrivalent Flu Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Quadrivalent Flu Vaccine Sales by Type (2016-2026)
7.2 North America Quadrivalent Flu Vaccine Sales by Application (2016-2026)
7.3 North America Quadrivalent Flu Vaccine Market Size by Country
7.3.1 North America Quadrivalent Flu Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Quadrivalent Flu Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Quadrivalent Flu Vaccine Sales by Type (2016-2026)
8.2 Europe Quadrivalent Flu Vaccine Sales by Application (2016-2026)
8.3 Europe Quadrivalent Flu Vaccine Market Size by Country
8.3.1 Europe Quadrivalent Flu Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Quadrivalent Flu Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Quadrivalent Flu Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Quadrivalent Flu Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Quadrivalent Flu Vaccine Market Size by Region
9.3.1 Asia-Pacific Quadrivalent Flu Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Quadrivalent Flu Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Quadrivalent Flu Vaccine Sales by Type (2016-2026)
10.2 South America Quadrivalent Flu Vaccine Sales by Application (2016-2026)
10.3 South America Quadrivalent Flu Vaccine Market Size by Country
10.3.1 South America Quadrivalent Flu Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Quadrivalent Flu Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Quadrivalent Flu Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Quadrivalent Flu Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Quadrivalent Flu Vaccine Market Size by Country
11.3.1 Middle East & Africa Quadrivalent Flu Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Quadrivalent Flu Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Quadrivalent Flu Vaccine Typical Distributors
12.3 Quadrivalent Flu Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Quadrivalent Flu Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Quadrivalent Flu Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur Quadrivalent Flu Vaccine Product and Services
Table 6. Sanofi Pasteur Quadrivalent Flu Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Major Business
Table 9. AstraZeneca Quadrivalent Flu Vaccine Product and Services
Table 10. AstraZeneca Quadrivalent Flu Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. CSL Basic Information, Manufacturing Base and Competitors
Table 12. CSL Major Business
Table 13. CSL Quadrivalent Flu Vaccine Product and Services
Table 14. CSL Quadrivalent Flu Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Abbott Basic Information, Manufacturing Base and Competitors
Table 16. Abbott Major Business
Table 17. Abbott Quadrivalent Flu Vaccine Product and Services
Table 18. Abbott Quadrivalent Flu Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Major Business
Table 21. GlaxoSmithKline Quadrivalent Flu Vaccine Product and Services
Table 22. GlaxoSmithKline Quadrivalent Flu Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Quadrivalent Flu Vaccine Sales by Manufacturer (2019-2021e) & (K Doses)
Table 24. Global Quadrivalent Flu Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Quadrivalent Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Quadrivalent Flu Vaccine Production Capacity by Company, (K Doses): 2020 VS 2021
Table 27. Head Office and Quadrivalent Flu Vaccine Production Site of Key Manufacturer
Table 28. Global Quadrivalent Flu Vaccine Sales by Region (2016-2021e) & (K Doses)
Table 29. Global Quadrivalent Flu Vaccine Sales by Region (2021-2026) & (K Doses)
Table 30. Global Quadrivalent Flu Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 31. Global Quadrivalent Flu Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 32. Global Quadrivalent Flu Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 33. Global Quadrivalent Flu Vaccine Sales by Type (2021-2026) & (K Doses)
Table 34. Global Quadrivalent Flu Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 35. Global Quadrivalent Flu Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 36. Global Quadrivalent Flu Vaccine Price by Type (2016-2021e) & (USD/Dose)
Table 37. Global Quadrivalent Flu Vaccine Price by Type (2021-2026) & (USD/Dose)
Table 38. Global Quadrivalent Flu Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 39. Global Quadrivalent Flu Vaccine Sales by Application (2021-2026) & (K Doses)
Table 40. Global Quadrivalent Flu Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 41. Global Quadrivalent Flu Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 42. Global Quadrivalent Flu Vaccine Price by Application (2016-2021e) & (USD/Dose)
Table 43. Global Quadrivalent Flu Vaccine Price by Application (2021-2026) & (USD/Dose)
Table 44. North America Quadrivalent Flu Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 45. North America Quadrivalent Flu Vaccine Sales by Country (2021-2026) & (K Doses)
Table 46. North America Quadrivalent Flu Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 47. North America Quadrivalent Flu Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 48. North America Quadrivalent Flu Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 49. North America Quadrivalent Flu Vaccine Sales by Type (2021-2026) & (K Doses)
Table 50. North America Quadrivalent Flu Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 51. North America Quadrivalent Flu Vaccine Sales by Application (2021-2026) & (K Doses)
Table 52. Europe Quadrivalent Flu Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 53. Europe Quadrivalent Flu Vaccine Sales by Country (2021-2026) & (K Doses)
Table 54. Europe Quadrivalent Flu Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 55. Europe Quadrivalent Flu Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 56. Europe Quadrivalent Flu Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 57. Europe Quadrivalent Flu Vaccine Sales by Type (2021-2026) & (K Doses)
Table 58. Europe Quadrivalent Flu Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 59. Europe Quadrivalent Flu Vaccine Sales by Application (2021-2026) & (K Doses)
Table 60. Asia-Pacific Quadrivalent Flu Vaccine Sales by Region (2016-2021e) & (K Doses)
Table 61. Asia-Pacific Quadrivalent Flu Vaccine Sales by Region (2021-2026) & (K Doses)
Table 62. Asia-Pacific Quadrivalent Flu Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 63. Asia-Pacific Quadrivalent Flu Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 64. Asia-Pacific Quadrivalent Flu Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 65. Asia-Pacific Quadrivalent Flu Vaccine Sales by Type (2021-2026) & (K Doses)
Table 66. Asia-Pacific Quadrivalent Flu Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 67. Asia-Pacific Quadrivalent Flu Vaccine Sales by Application (2021-2026) & (K Doses)
Table 68. South America Quadrivalent Flu Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 69. South America Quadrivalent Flu Vaccine Sales by Country (2021-2026) & (K Doses)
Table 70. South America Quadrivalent Flu Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 71. South America Quadrivalent Flu Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 72. South America Quadrivalent Flu Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 73. South America Quadrivalent Flu Vaccine Sales by Type (2021-2026) & (K Doses)
Table 74. South America Quadrivalent Flu Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 75. South America Quadrivalent Flu Vaccine Sales by Application (2021-2026) & (K Doses)
Table 76. Middle East & Africa Quadrivalent Flu Vaccine Sales by Country (2016-2021e) & (K Doses)
Table 77. Middle East & Africa Quadrivalent Flu Vaccine Sales by Country (2021-2026) & (K Doses)
Table 78. Middle East & Africa Quadrivalent Flu Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 79. Middle East & Africa Quadrivalent Flu Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 80. Middle East & Africa Quadrivalent Flu Vaccine Sales by Type (2016-2021e) & (K Doses)
Table 81. Middle East & Africa Quadrivalent Flu Vaccine Sales by Type (2021-2026) & (K Doses)
Table 82. Middle East & Africa Quadrivalent Flu Vaccine Sales by Application (2016-2021e) & (K Doses)
Table 83. Middle East & Africa Quadrivalent Flu Vaccine Sales by Application (2021-2026) & (K Doses)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Quadrivalent Flu Vaccine Typical Distributors
Table 87. Quadrivalent Flu Vaccine Typical Customers
List of Figures
Figure 1. Quadrivalent Flu Vaccine Picture
Figure 2. Global Quadrivalent Flu Vaccine Sales Market Share by Type in 2020
Figure 3. Intramuscular Injection
Figure 4. Nasal Spray
Figure 5. Intradermal Shot
Figure 6. Global Quadrivalent Flu Vaccine Sales Market Share by Application in 2020
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Public Health Agency
Figure 10. Other
Figure 11. Global Quadrivalent Flu Vaccine Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
Figure 12. Global Quadrivalent Flu Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Quadrivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Quadrivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Quadrivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Quadrivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Quadrivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Quadrivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Quadrivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Quadrivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Quadrivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Quadrivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Quadrivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Quadrivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Quadrivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Quadrivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Quadrivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Quadrivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Quadrivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Quadrivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Quadrivalent Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Quadrivalent Flu Vaccine Sales (2016-2026) & (K Doses)
Figure 33. Global Quadrivalent Flu Vaccine Production Capacity (2016-2026) & (K Doses)
Figure 34. Global Quadrivalent Flu Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Quadrivalent Flu Vaccine Market Drivers
Figure 36. Quadrivalent Flu Vaccine Market Restraints
Figure 37. Quadrivalent Flu Vaccine Market Trends
Figure 38. Global Quadrivalent Flu Vaccine Sales Market Share by Manufacturer in 2020
Figure 39. Global Quadrivalent Flu Vaccine Revenue Market Share by Manufacturer in 2020
Figure 40. Quadrivalent Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Quadrivalent Flu Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Quadrivalent Flu Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Quadrivalent Flu Vaccine Sales Market Share by Region (2016-2026)
Figure 44. Global Quadrivalent Flu Vaccine Revenue Market Share by Region (2016-2026)
Figure 45. North America Quadrivalent Flu Vaccine Revenue (2016-2026) & (USD Million)
Figure 46. Europe Quadrivalent Flu Vaccine Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Quadrivalent Flu Vaccine Revenue (2016-2026) & (USD Million)
Figure 48. South America Quadrivalent Flu Vaccine Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Quadrivalent Flu Vaccine Revenue (2016-2026) & (USD Million)
Figure 50. Global Quadrivalent Flu Vaccine Sales Market Share by Type (2016-2026)
Figure 51. Global Quadrivalent Flu Vaccine Revenue Market Share by Type (2016-2026)
Figure 52. Global Quadrivalent Flu Vaccine Price by Type (2016-2026) & (USD/Dose)
Figure 53. Global Quadrivalent Flu Vaccine Sales Market Share by Application (2016-2026)
Figure 54. Global Quadrivalent Flu Vaccine Revenue Market Share by Application (2016-2026)
Figure 55. Global Quadrivalent Flu Vaccine Price by Application (2016-2026) & (USD/Dose)
Figure 56. North America Quadrivalent Flu Vaccine Sales Market Share by Country (2016-2026)
Figure 57. North America Quadrivalent Flu Vaccine Revenue Market Share by Country (2016-2026)
Figure 58. North America Quadrivalent Flu Vaccine Sales Market Share by Type (2016-2026)
Figure 59. North America Quadrivalent Flu Vaccine Sales Market Share by Application (2016-2026)
Figure 60. Europe Quadrivalent Flu Vaccine Sales Market Share by Country (2016-2026)
Figure 61. Europe Quadrivalent Flu Vaccine Revenue Market Share by Country (2016-2026)
Figure 62. Europe Quadrivalent Flu Vaccine Sales Market Share by Type (2016-2026)
Figure 63. Europe Quadrivalent Flu Vaccine Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Quadrivalent Flu Vaccine Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Quadrivalent Flu Vaccine Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Quadrivalent Flu Vaccine Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Quadrivalent Flu Vaccine Sales Market Share by Application (2016-2026)
Figure 68. South America Quadrivalent Flu Vaccine Sales Market Share by Country (2016-2026)
Figure 69. South America Quadrivalent Flu Vaccine Revenue Market Share by Country (2016-2026)
Figure 70. South America Quadrivalent Flu Vaccine Sales Market Share by Type (2016-2026)
Figure 71. South America Quadrivalent Flu Vaccine Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Quadrivalent Flu Vaccine Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Quadrivalent Flu Vaccine Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Quadrivalent Flu Vaccine Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Quadrivalent Flu Vaccine Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source

以下、関連資料のご紹介

世界のガーダシル（HPVワクチン）市場 2021：企業別、地域別、種類・用途別

Global Gardasil (HPV Vaccine) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X07671 2021年5月 103Pages
当調査資料では、ガーダシル（HPVワクチン）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ガーダシル（HPVワクチン）の種類別市場規模（HPV2バレントワクチン、HPV4バレントワクチン、HPV9バレントワクチン）、用途別市場規模（Hpv16タイプ、...

世界の子宮頸がんワクチン市場 2021：企業別、地域別、種類・用途別

Global Cervical Cancer Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X03577 2021年5月 104Pages
当調査資料では、子宮頸がんワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。子宮頸がんワクチンの種類別市場規模（2価ワクチン、4価ワクチン、9価ワクチン）、用途別市場規模（病院、バイオテクノロジー企業、学術研究機関、その他）、地域別市場規模（北米...

世界の三価インフルエンザワクチン市場 2021：企業別、地域別、種類・用途別

Global Trivalent Flu Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X17928 2021年5月 102Pages
当調査資料では、三価インフルエンザワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。三価インフルエンザワクチンの種類別市場規模（筋肉内注射、点鼻薬、皮内注射）、用途別市場規模（病院、クリニック、保健所、その他）、地域別市場規模（北米、アメリカ、ヨ...

世界のワクチン輸送箱市場 2021：企業別、地域別、種類・用途別

Global Vaccine Shipping Box Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X14900 2021年5月 103Pages
当調査資料では、ワクチン輸送箱のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ワクチン輸送箱の種類別市場規模（ドライアイス式ワクチン配送箱、圧縮式ワクチン輸送箱、その他）、用途別市場規模（病院、専門クリニック、その他）、地域別市場規模（北米、アメリカ、...

世界の遺伝子ワクチン市場 2021：企業別、地域別、種類・用途別

Global Genetic Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X07786 2021年5月 107Pages
当調査資料では、遺伝子ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遺伝子ワクチンの種類別市場規模（組換えタンパク質ワクチン、遺伝子ベースワクチン）、用途別市場規模（人、動物）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、...

世界のワクチン冷媒市場 2021：企業別、地域別、種類・用途別

Global Vaccine Refrigerant Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X14899 2021年5月 108Pages
当調査資料では、ワクチン冷媒のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ワクチン冷媒の種類別市場規模（R125、R410a、R23、その他）、用途別市場規模（ワクチン保管、ワクチン輸送、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界の水痘（水疱瘡）ワクチン市場 2021：企業別、地域別、種類・用途別

Global Chickenpox (Varicella) Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X03666 2021年5月 87Pages
当調査資料では、水痘（水疱瘡）ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。水痘（水疱瘡）ワクチンの種類別市場規模（一価ワクチン、混合ワクチン）、用途別市場規模（子供用注射、大人用注射）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中...

世界の肺炎球菌ワクチン市場 2021：企業別、地域別、種類・用途別

Global Pneumonia Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X16526 2021年5月 105Pages
当調査資料では、肺炎球菌ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。肺炎球菌ワクチンの種類別市場規模（肺炎球菌結合型ワクチン（PCV13）、肺炎球菌多糖ワクチン（PPSV23））、用途別市場規模（肺炎、髄膜炎、敗血症）、地域別市場規模（北米...

世界の三価インフルエンザワクチン市場 2021：企業別、地域別、種類・用途別 The Trivalent Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
ヒトパピローマウイルスワクチンの世界市場2018-2025 Human papilloma virus (HPV) vaccine is a vaccine that prevents infection by certain types of human papillomavirus.In 2018, the global Human Papillomavirus Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been…
世界の点鼻スプレー式インフルエンザワクチン市場 2021：企業別、地域別、種類・用途別 The Nasal Spray Flu Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
HPV治療ワクチンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Human papilloma virus (HPV) vaccines are used to protect against HPV infections. Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papillom…
クロストリジウムワクチン（動物の健康）の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Clostridium vaccines are used to provide immunity against for a variety of ovine and bovine clostridial diseases such as tetanus, black disease, pulpy kidney (enterotoxaemia), and blackleg. Scope of the Report: This report focuses on the Clostridium Vaccine (Animal Health) in global market, especial…